Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bokemeyer

Showing results (201-210 of 333) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancerC Bokemeyer, A Gerl, P Schöffski, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 9, 2004
[Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker]A C Pfannenberg, K Oechsle, C Kollmannsberger, et al.
BMC Cancer|November 10, 2016
Improved nutrition in adolescents and young adults after childhood cancer - INAYA studyJ Quidde, J von Grundherr, B Koch, et al.
Cancer|July 19, 2002
Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancerC Kollmannsberger, F Mayer, H Pressler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 1, 1997
[An interdisciplinary consensus conference on the diagnosis and therapy of testicular tumors]M Bamberg, H J Schmoll, L Weissbach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumorsC Bokemeyer, O Köhrmann, J Tischler, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumoursC Schöber, E Schmoll, H J Schmoll, et al.
Anti-Cancer Drugs|April 1, 1997
A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancerC Bokemeyer, C S Lampe, M R Clemens, et al.
Oncology Reports|February 12, 1998
The MXI1 tumor suppressor gene is not mutated in primary prostate cancerM A Kuczyk, J Serth, C Bokemeyer, et al.
Journal of Thrombosis and Haemostasis : JTH|May 13, 2006
Experimental metastasis and primary tumor growth in mice with hemophilia AF Langer, A Amirkhosravi, S B Ingersoll, et al.
Pageof 34

Showing results (201-210 of 333) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancerC Bokemeyer, A Gerl, P Schöffski, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 9, 2004
[Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker]A C Pfannenberg, K Oechsle, C Kollmannsberger, et al.
BMC Cancer|November 10, 2016
Improved nutrition in adolescents and young adults after childhood cancer - INAYA studyJ Quidde, J von Grundherr, B Koch, et al.
Cancer|July 19, 2002
Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancerC Kollmannsberger, F Mayer, H Pressler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 1, 1997
[An interdisciplinary consensus conference on the diagnosis and therapy of testicular tumors]M Bamberg, H J Schmoll, L Weissbach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumorsC Bokemeyer, O Köhrmann, J Tischler, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumoursC Schöber, E Schmoll, H J Schmoll, et al.
Anti-Cancer Drugs|April 1, 1997
A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancerC Bokemeyer, C S Lampe, M R Clemens, et al.
Oncology Reports|February 12, 1998
The MXI1 tumor suppressor gene is not mutated in primary prostate cancerM A Kuczyk, J Serth, C Bokemeyer, et al.
Journal of Thrombosis and Haemostasis : JTH|May 13, 2006
Experimental metastasis and primary tumor growth in mice with hemophilia AF Langer, A Amirkhosravi, S B Ingersoll, et al.
Pageof 34